v3.25.2
STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

NOTE 5: STOCK-BASED COMPENSATION

 

The Company has an equity incentive plan for grants to employees, officers, consultants, directors, and other service providers that was approved in 2021 (the “2021 Plan”). The 2021 Plan provides for the grant of non-qualified stock options, incentive stock options, restricted stock awards, restricted stock units, unrestricted stock awards, stock appreciation rights and other forms of stock-based compensation. The 2021 Plan permits the Company’s board to change the type, terms, and conditions of awards as circumstances may change. This flexibility to adjust the type of compensation to be granted is particularly important given current economic and world events.

 

 

A summary of the stock option activity during the period ended June 30, 2025, is presented in the table below:

 

  

       Weighted average     
   Number of
options
   Exercise
price
   Remaining
contractual
life
(in years)
   Intrinsic value 
Outstanding as of January 1, 2025   103,114   $225.68    7.6   $- 
Granted   3,301   $9.24    -   $4,258 
Forfeited and cancelled   (1,749)  $-    -   $- 
Outstanding as of June 30, 2025   104,666   $125.42    7.3   $4,258 
Exercisable as of June 30, 2025   76,579   $158.51    6.7   $- 
Vested and expected to vest as of June 30, 2025   104,666   $125.42    7.3   $4,258 

 

 

The following table summarizes the total stock-based compensation expense included in the unaudited condensed consolidated statements of operations for the periods presented:

  

   2025   2024   2025   2024 
   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2025   2024   2025   2024 
Research and development  $59,867   $221,661   $129,529   $439,480 
General and administrative   120,896    561,191    292,125    1,118,063 
Total stock-based compensation expense  $180,763   $782,852   $421,654   $1,557,543 

 

As of June 30, 2025, total compensation cost not yet recognized related to unvested stock options was approximately $0.6 million, which is expected to be recognized over a weighted-average period of approximately 1.2 years.

 

The Company estimates the fair value of stock options on the date of grant using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires estimates of highly subjective assumptions, which affect the fair value of each stock option. The weighted average inputs used to measure the value of the options granted during the six months ended June 30, 2025, are presented in the table below. The weighted average fair value of stock options granted during the six months ended June 30, 2025 was $8.14 per share.

 

   2025 
Exercise price  $9.24 
Expected term (in years)   5.5 
Volatility   128.4%
Risk free rate   4.1%
Dividend yield   0%

 

The following table presents the exercise price of outstanding stock options as of June 30, 2025:

  

Exercise price  Options
outstanding
 
     
$0.01 - $80.00   56,047 
$0.01 - $80.00   56,047 
$80.01 or higher   48,619 
Total   104,666